Insulet Corp

• Country

  United States of America

• Sector

  Health Care

• Industry group

  Health Care Equipment & Services

• Industry

  Health Care Equipment & Supplies

• Sub-sector

  Health Care

• Capitalization (millions of $)

  12252.3

• Ticker

  PODD.O

• ISIN

  US45784P1012

• IPO date

  2007-05-15

• Availability on Russian exchanges

  Yes

• Reporting for

  2024-02-23

• Date fact. publication of reports

  2023-12-31

Insulet Corporation is primarily engaged in the development, manufacture and sale of its proprietary Omnipod System, a continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod Insulin Management System (Omnipod), the Omnipod DASHTM Insulin Management System (Omnipod DASH) and its digital mobile Omnipod platform. The Omnipod System features two devices: a small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod) and a Personal Diabetes Manager (PDM). Users has to fill the Pod with insulin and wear directly on the body. It can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh or lower back. The Pod delivers precise, personalized doses of insulin into the body through a small flexible tube, cannula. PDM is a wireless, handheld device that programs the Pod with the user’s personalized insulin-delivery instructions and wirelessly monitors the Pod’s operation.